Thursday, March 19

Healthcare

GSK stock climbs on Delaware court ruling in Zantac case

08/28/20241 Min Read

case climbs court Delaware GSK ruling stock Zantac

Previous ArticleCVS Health's Aetna expands fertility treatment coverage

Next Article Weight loss drug developers slump as Eli Lilly slashes cost of some Zepbound doses